×
About 7,513 results

ALLMedicine™ Malignant Melanoma Center

Research & Reviews  2,634 results

Noncontrast-enhanced 3-Tesla MRI using surface coil as a complementary test for assessm...
https://doi.org/10.1097/CMR.0000000000000828
Melanoma Research; Seyed Jafari SM, Mazinani M et. al.

May 18th, 2022 - Locoregional and distant metastases account for most cases of morbidity and mortality associated with melanoma. In addition, local recurrences of melanoma might be the onset of disseminated disease. Therefore, precise diagnosis and therapy are war...

Impact of the Covid-19 pandemic on Melanoma and Non-melanoma skin cancer inpatient trea...
https://doi.org/10.1111/jdv.18217
Journal of the European Academy of Dermatology and Venere... Kleemann J, Meissner M et. al.

May 17th, 2022 - SARS-CoV-2 has massively changed the care situation in hospitals worldwide. Although tumor care should not be affected, initial reports from European countries were suggestive for a decrease in skin cancer during the first pandemic wave and only l...

The significance of intratumoural CD163+ macrophages in oral malignant melanoma: A prel...
https://doi.org/10.1111/odi.14252
Oral Diseases; Kodama T, Shigeoka M et. al.

May 15th, 2022 - The significance of intratumoural CD163+ macrophages in oral malignant melanoma: A preliminary study.|2022|Kodama T,Shigeoka M,Nishio M,Koma YI,Akashi M,|

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02133196

May 13th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
https://clinicaltrials.gov/ct2/show/NCT05019534

May 12th, 2022 - BRAF mutation exists in about 10-12% of colorectal cancer, among which BRAF V600E mutation is the most common type, which is an important biomarker for predicting the prognosis and precise treatment efficacy of metastatic colorectal cancer (mCRC)....

see more →

Guidelines  2 results

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cance...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5882649
International Journal of Clinical Oncology; Saito T, Tabata T et. al.

Nov 22nd, 2017 - Vulvar cancer and vaginal cancer are relatively rare tumors, and there had been no established treatment principles or guidelines to treat these rare tumors in Japan. The first version of the Japan Society of Gynecologic Oncology (JSGO) guidelines...

Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment an...
https://doi.org/10.1093/annonc/mdn100
Annals of Oncology : Official Journal of the European Soc... Dummer R, Hauschild A et. al.

May 9th, 2008 - Cutaneous malignant melanoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.|2008|Dummer R,Hauschild A,Jost L, ,|diagnosis,epidemiology,pathology,therapy,diagnosis,epidemiology,pathology,therapy,

see more →

Drugs  9 results see all →

Clinicaltrials.gov  109 results

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
https://clinicaltrials.gov/ct2/show/NCT02133196

May 13th, 2022 - Background: Patients with metastatic non-small cell lung cancer (NSCLC) have few approved therapeutic options and those that exist are of transient benefit. Recent clinical experiences with experimental agents that release checkpoints on the host ...

Tolerability and Safety of Vemurafenib, Cetuximab Combined With Camrelizumab for BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
https://clinicaltrials.gov/ct2/show/NCT05019534

May 12th, 2022 - BRAF mutation exists in about 10-12% of colorectal cancer, among which BRAF V600E mutation is the most common type, which is an important biomarker for predicting the prognosis and precise treatment efficacy of metastatic colorectal cancer (mCRC)....

Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma
https://clinicaltrials.gov/ct2/show/NCT02410733

Apr 26th, 2022 - The Lipo-MERIT vaccine consists of four naked ribonucleic acid (RNA)-drug products (DPs) that are optimized to induce antigen-specific cluster of differentiation (CD)8+ and CD4+ T cell responses against the four selected malignant melanoma-associa...

Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
https://clinicaltrials.gov/ct2/show/NCT02906943

Apr 22nd, 2022 - A recent survey of clinical genetic testing laboratories for cancer diagnostics by the Molecular Oncology Advisory Committee for Cancer Care Ontario identified disparities in access and use patterns for next generation sequencing (NGS) across the ...

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
https://clinicaltrials.gov/ct2/show/NCT04056247

Apr 19th, 2022 - The goal of this research study is to develop an algorithm that predicts the patient's treatment outcome.This algorithm will serve as a tool for physicians when making treatment decisions, specifically for stage IV NSCLC and malignant melanoma pat...

see more →

News  251 results

Skill Checkup: A 73-Year-Old Woman With Resected Melanoma in the Cervical Spine
https://www.medscape.com/viewarticle/969171

Apr 6th, 2022 - The Skill Checkup series provides a quick, case-style interactive quiz highlighting key guidelines- and evidence-based information to inform clinical practice. A 73-year-old woman presented for follow-up of malignant melanoma. The melanoma was res...

Adverse Skin Effects of Cancer Immunotherapy Reviewed
https://www.medscape.com/viewarticle/970581

Mar 18th, 2022 - Immune checkpoint inhibitors (ICIs) have unquestionably revolutionized the care of patients with malignant melanoma, non-small cell lung cancer, and other types of cancer. But about 40% of patients with cancer treated with ICIs will experience imm...

Fast Five Quiz: Metastatic Melanoma
https://www.medscape.com/viewarticle/966638

Feb 23rd, 2022 - Malignant melanoma is the third most common cutaneous cancer after basal cell carcinoma and squamous cell carcinoma. Although most malignant melanomas are diagnosed at an early stage, this cancer also has the inherent ability to spread aggressivel...

Fast Five Quiz: Genetic/Biomarker Testing in Melanoma
https://www.medscape.com/viewarticle/966637

Feb 22nd, 2022 - Malignant melanoma is the fifth most common cancer, with an estimated 106,110 new cases in the United States in 2021. The incidence of malignant melanoma has been on the rise globally and trails only lung cancer in women in terms of the rate of in...

Pencil-core Granuloma Forming 62 Years After Initial Injury
https://www.mdedge.com/dermatology/article/251392/wounds/pencil-core-granuloma-forming-62-years-after-initial-injury
Blake R. Zelickson, MD, PhD, Leonard H. Goldberg, MD et. al.

Feb 3rd, 2022 - To the Editor: Trauma from a pencil tip can sometimes result in a fragment of lead being left embedded within the skin. Pencil lead is composed of 66% graphite carbon, 26% aluminum silicate, and 8% paraffin.

see more →